We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$61.3M
Cap. Flow
+$16M
Cap. Flow %
1.52%
Top 10 Hldgs %
75.78%
Holding
322
New
54
Increased
182
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$36.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.8M
3
GLD icon
SPDR Gold Trust
GLD
+$6.52M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.77M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$4.1M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$29.9M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$24M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$22.8M
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$6.4M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$2.65M

Sector Composition

Rank Sector Weight
1 Technology 1.16%
2 Consumer Discretionary 0.55%
3 Financials 0.43%
4 Communication Services 0.39%
5 Healthcare 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEO icon
251
American Eagle Outfitters
AEO
$2.93B
$8.7K ﹤0.01%
396
+352
+800% +$7.26K
UVSP icon
252
Univest Financial
UVSP
$1.17B
$8.63K ﹤0.01%
317
+282
+806% +$7.52K
NOG icon
253
Northern Oil and Gas
NOG
$2.55B
$8.37K ﹤0.01%
238
+212
+815% +$8.09K
VAL icon
254
Valaris
VAL
$6.1B
$8.35K ﹤0.01%
149
+133
+831% +$8.71K
CAL icon
255
Caleres
CAL
$479M
$7.28K ﹤0.01%
+218
New +$7.91K
CLDX icon
256
Celldex Therapeutics
CLDX
$3.49B
$6.08K ﹤0.01%
183
+158
+632% +$6.02K
PENG
257
Penguin Solutions Inc
PENG
$2.93B
$6.01K ﹤0.01%
282
+242
+605% +$5.21K
RCKY icon
258
Rocky Brands
RCKY
$358M
$5.88K ﹤0.01%
185
+159
+612% +$5.05K
DIOD icon
259
Diodes
DIOD
$4.72B
$5.85K ﹤0.01%
92
+79
+608% +$5.47K
BKU icon
260
Bankunited
BKU
$3.35B
$5.16K ﹤0.01%
145
+124
+590% +$4.4K
AAP icon
261
Advance Auto Parts
AAP
$3.31B
$4.97K ﹤0.01%
120
+103
+606% +$5.46K
FNWB icon
262
First Northwest Bancorp
FNWB
$108M
$3.77K ﹤0.01%
351
+301
+602% +$3.12K
REGN icon
263
Regeneron Pharmaceuticals
REGN
$83.3B
$3.13K ﹤0.01%
+3
New +$3.34K
PEN icon
264
Penumbra
PEN
$12.9B
$2.49K ﹤0.01%
+13
New +$2.46K
PODD icon
265
Insulet
PODD
$9.96B
$2.09K ﹤0.01%
+9
New +$1.85K
ARVN icon
266
Arvinas
ARVN
$586M
$1.98K ﹤0.01%
80
+68
+567% +$1.78K
ALNY icon
267
Alnylam Pharmaceuticals
ALNY
$29.4B
$1.92K ﹤0.01%
+7
New +$1.82K
SYK icon
268
Stryker
SYK
$133B
$1.44K ﹤0.01%
+4
New +$1.38K
LEGN icon
269
Legend Biotech
LEGN
$4.2B
$1.38K ﹤0.01%
+28
New +$1.49K
EXAS
270
DELISTED
Exact Sciences
EXAS
$1.25K ﹤0.01%
+19
New +$1.07K
INSP icon
271
Inspire Medical Systems
INSP
$1.74B
$1.22K ﹤0.01%
+6
New +$1.04K
MASI
272
DELISTED
Masimo
MASI
$1.2K ﹤0.01%
+9
New +$1.04K
SGRY icon
273
Surgery Partners
SGRY
$1.99B
$1.15K ﹤0.01%
+36
New +$1.06K
GKOS icon
274
Glaukos
GKOS
$10.7B
$1.03K ﹤0.01%
+8
New +$996
CVS icon
275
CVS Health
CVS
$119B
$921 ﹤0.01%
+15
New +$875
9 10
11
12 13

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

J. Safra Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, J. Safra Asset Management held 322 positions worth $1.05B, up 6.2% from $991M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

J. Safra Asset Management's Q3 2024 filing shows 54 new, 182 increased, 11 reduced and 24 closed positions. Its largest new stake was Quest Diagnostics: 1,087 shares worth $168K. The largest sale was VanEck Semiconductor ETF, an estimated $29.9M.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, up from 0.88% a quarter earlier, followed by Consumer Discretionary and Financials.

  • J. Safra Asset Management's largest Q3 2024 buy was Quest Diagnostics: 1,087 shares worth $168K.
  • J. Safra Asset Management added most to Invesco S&P 500 Equal Weight ETF in Q3 2024, an estimated $36.6M increase.
  • J. Safra Asset Management's biggest Q3 2024 reduction was VanEck Semiconductor ETF, cutting an estimated $29.9M.
  • J. Safra Asset Management fully exited Global X Uranium ETF in Q3 2024, selling an estimated $403K.
  • J. Safra Asset Management's ten largest holdings make up 76% of its $1.05B portfolio in Q3 2024.
  • J. Safra Asset Management opened 54 new positions and closed 24 in Q3 2024.
  • J. Safra Asset Management's portfolio value rose 6.2% quarter-over-quarter to $1.05B.

Based on J. Safra Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.